Literature DB >> 16760660

Checking in on hypoxia/reoxygenation.

Rachel A Freiberg1, Adam J Krieg, Amato J Giaccia, Ester M Hammond.   

Abstract

Hypoxia/reoxygenation is a physiological stress that activates the DNA damage pathway. Significantly, this pathway is initiated during hypoxia, in the absence of detectable DNA damage. Our most recent study determined that during hypoxia, Chk 2 is phosphorylated in an ATM-dependent manner. In addition to this finding, we found that components of the MRN complex were not required for Chk 2 phosphorylation during hypoxia/reoxygenation. Once activated, Chk 2 initiates a signaling cascade, which induces a cell cycle arrest in the G2 phase. Loss of the Chk 2-mediated arrest correlated with an increase in sensitivity to hypoxia/reoxygenation. In contrast, loss of a p53-mediated reoxygenation-induced G1 arrest does not correlate with increased sensitivity to hypoxia/reoxygenation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760660     DOI: 10.4161/cc.5.12.2811

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis.

Authors:  Kai Bartkowiak; Sabine Riethdorf; Klaus Pantel
Journal:  Cancer Microenviron       Date:  2011-05-31

Review 2.  Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  DNA Repair (Amst)       Date:  2015-05-01

3.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

4.  CGGBP1 regulates cell cycle in cancer cells.

Authors:  Umashankar Singh; Pernilla Roswall; Lene Uhrbom; Bengt Westermark
Journal:  BMC Mol Biol       Date:  2011-07-07       Impact factor: 2.946

5.  Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage.

Authors:  Seema Betigeri; Min Zhang; Olga Garbuzenko; Tamara Minko
Journal:  Drug Deliv Transl Res       Date:  2010-12-14       Impact factor: 4.617

6.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

7.  Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1.

Authors:  Katarzyna B Leszczynska; Eva-Leonne Göttgens; Deborah Biasoli; Monica M Olcina; Jonathan Ient; Selvakumar Anbalagan; Stephan Bernhardt; Amato J Giaccia; Ester M Hammond
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

8.  Cell-line dependent effects of hypoxia prior to irradiation in squamous cell carcinoma lines.

Authors:  Franziska Hauth; Mahmoud Toulany; Daniel Zips; Apostolos Menegakis
Journal:  Clin Transl Radiat Oncol       Date:  2017-07-04

Review 9.  Targeting hypoxic cells through the DNA damage response.

Authors:  Monica Olcina; Philip S Lecane; Ester M Hammond
Journal:  Clin Cancer Res       Date:  2010-09-27       Impact factor: 12.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.